Center for Behavioral Health Statistics and Quality. Key substance use and mental health indicators in the United States: results from the 2021 National Survey on Drug Use and Health (HHS Publication No. PEP22-07-01-005). 2021. Accessed July 2024. http://www.samhsa.gov/data/
2.
MoradianSTeufelMJahreL, et al. Mental health burden of patients with diabetes before and after the initial outbreak of COVID-19: predictors of mental health impairment. BMC Public Health. 2021;21(1):2068. doi:10.1186/s12889-021-12101-z
3.
AlessiJBergerdeOliveiraGFrancoDW, et al. Mental health in the era of COVID-19: prevalence of psychiatric disorders in a cohort of patients with type 1 and type 2 diabetes during the social distancing. Diabetol Metab Syndr. 2020;12:76. doi:10.1186/s13098-020-00584-6
4.
GonzalvoJDdeGrootMRinkerJ, et al. Mental health in people with diabetes: a needs assessment for the diabetes educator. AADE in Practice. 2018;6(5):30-35.
5.
Young-HymanDde GrootMHill-BriggsF, et al. Psycho-social care for people with diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2016;39:2126-2140.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Health Disorders. 5th ed - TR. American Psychiatric Association; 2022.
8.
AndersonRJFreedlandKEClouseRELustmanPJ.The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24:1069-1078.
9.
McGillDEVolkeningLKPoberMD, et al. Depressive symptoms at critical times in youth with type 1 diabetes: following type 1 diabetes diagnosis and insulin pump initiation. J Adolesc Health. 2018;62(2):219-225.
10.
HoodKKHuestisSMaherA, et al. Depressive symptoms in children and adolescents with type 1 diabetes: association with diabetes-specific characteristics. Diabetes Care. 2006;29(6):1389-1391.
11.
MatlockKAJonesMHCorathersSDKichlerJC.Clinical and psychosocial factors associated with suicidal ideation in adolescents with type 1 diabetes. J Adolesc Health2017;61(4):471-477.
12.
Van BurenDJWilfleyDEMarcusMD, et al. Depressive symptoms and glycemic control in youth with type 2 diabetes participating in the TODAY clinical trial. Diabetes Res Clin Pract. 2018;135:85-87.
13.
SilversteinJChengPRuedyKJ, et al. Depressive symptoms in youth with type 1 or type 2 diabetes: results of the pediatrics diabetes consortium screening assessment of depressing in diabetes study. Diabetes Care. 2015;38(12):2341-3433.
14.
KoyamaAKHoraIABullardKMBenoitSRTangSChoP.State-specific prevalence of depression among adults with and without diabetes — United States, 2011-2019. Prev Chronic Dis2023;20:220407. https://www.cdc.gov/pcd/issues/2023/22_0407.htm
15.
de GrootMCrickKALongM, et al. Lifetime duration of depressive disorders in patients with type 2 diabetes. Diabetes Care. 2016;39(12):2174-2181.
16.
KesslerRCBerglundPDemlerO, et al. National Comor-bidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095-3105.
17.
LustmanPJGriffithLSClouseRE.Depression in adults with diabetes. Results of 5-yr follow-up study. Diabetes Care. 1988;11:605-612.
18.
GoldenSHLazoMCarnethonM, et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA. 2008;299:2751-2759.
19.
MezukBEatonWWAlbrechtSGoldenSHDepression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008;31:2383-2390.
20.
LustmanPJAndersonRJFreedlandKE, et al. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care. 2000;23,934-942.
21.
de GrootMAndersonRFreedlandKE, et al. Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001;63:619-630.
22.
CiechanowskiPSKatonWJRussoJE.Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000;160:3278-3285.
23.
Von KorffMKatonWLinEH, et al. Potentially modifiable factors associated with disability among people with diabetes. Psychosom Med. 2005;67:233-240.
24.
LinEHHeckbertSRRutterCM, et al. Depression and increased mortality in diabetes: unexpected causes of death. Ann Fam Med. 2009;7:414-421.
25.
KatonWJRutterCSimonG, et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care. 2005;28:2668-2672.
26.
de GrootMDoyleTAverytJ. Program ACTIVE: cognitive behavioral therapy to treat depression in adults with type 2 diabetes in rural Appalachia. J Cogn Psychother. 2017;33(1):158-170.
27.
PietteJDRichardsonCHimleJ, et al. A randomized trial of telephonic counseling plus walking for depressed diabetes patients. Med Care. 2011;49(7):641-648.
28.
LustmanPJGriffithLS.Cognitive behavior therapy for depression in type 2 diabetes mellitus. Ann Intern Med. 1998;129(8):613-621.
29.
KalraSJenaBNYeravdekarR.Emotional and psychological needs of people with diabetes. Indian J Endocrinol Metab. 2018;22(5):696-704. doi:10.4103/ijem.IJEM_579_17
30.
FisherLHesslerDMPolonskyWH, et al. When is diabetes distress clinically meaningful? Establishing cut points for the Diabetes Distress Scale. Diabetes Care. 2012;35:259-264.
31.
HaggerVHendrieckxCSturtJ., et al. Diabetes distress among adolescents with type 1 diabetes: a systematic review. Curr Diab Rep. 2016;16:9. doi:10.1007/s11892-015-0694-2.
32.
HesslerDFisherLPolonskyWJohnsonN.Understanding the areas and correlates of diabetes-related distress in parents of teens with type 1 diabetes. J Pediatr Psychol. 2016;41(7):750-758.
33.
GrigsbyABAndersonRJFreedlandKE, et al. Prevalence of anxiety in adults with diabetes: a systematic review. J Psycho-som Res. 2002;53:1053-1060.
34.
HermannsNKulzerBKrichbaumM, et al. Affective and anxiety disorders in a German sample of diabetic patients: prevalence, comorbidity and risk factors. Diabet Med. 2005;22;293-300.
35.
RechenbergKWhittemoreRGreyM.Anxiety in youth with type 1 diabetes. J Pediatr Nurs. 2017;32:64-71.
36.
SmithKJBelandMClydeM, et al. Association of diabetes with anxiety: a systematic review and meta-analysis. J Psycho-som Res. 2013;74:89-99.
37.
FisherLSkaffMMMullanJT, et al. A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with type 2 diabetes. Diabet Med. 2008;25:1096-1101.
38.
AtlantisEVogelzangsNCashmanK, et al. Common mental disorders associated with 2-year diabetes incidence: the Netherlands Study of Depression and Anxiety (NESDA). J Affect Disord. 2012;142:S30-S35.
39.
HusarewyczMNEl-GabalawyRLogsettyS, et al. The association between number and type of traumatic life experiences and physical conditions in a nationally representative sample. Gen Hosp Psychiatry. 2014;36:26-32.
40.
SnoekFJPouwerFWelchGW, et al. Diabetes-related emotional distress in Dutch and U.S. diabetic patients: cross-cultural validity of the problem areas in diabetes scale. Diabetes Care. 2000;23:1305-1309.
41.
ShepardJAVajdaKNyerM, et al. Understanding the construct of fear of hypoglycemia in pediatric type 1 diabetes. J Pediatr Psychol. 2014;39:1115-1125.
42.
BahrmannAAbelAZeyfangA, et al. Psychological insulin resistance in geriatric patients with diabetes mellitus. Patient Educ Couns. 2014;94:417-422.
43.
van SonJNyklícekIPopV, et al. The effects of a mindful-ness-based intervention on emotional distress, quality of life, and HbA(1c) in outpatients with diabetes (DiaMind): a randomized controlled trial. Diabetes Care. 2013;36(4):823-830.
44.
CoxDJGonder-FrederickLPolonskyW, et al. Blood glucose awareness training (BGAT-2): long-term benefits. Diabetes Care. 2001;24:637-642.
45.
YoungVEiserCJohnsonB, et al. Eating problems in adolescents with type 1 diabetes: a systematic review with meta-analysis. Diabet Med. 2013;30:189-198.
46.
RodinGOlmstedMPRydallAC, et al. Eating disorders in young women with type 1 diabetes mellitus. J Psychosom Res. 2002;53:943-949.
47.
Goebel-FabbriAE.Disturbed eating behaviors and eating disorders in type 1 diabetes: clinical significance and treatment recommendations. Curr Diab Rep. 2009;9:133-139.
48.
Young-HymanD.Eating disorders and disordered eating behavior. In: Young-HymanDPeyrotM, eds. Psychosocial Care for People With Diabetes. American Diabetes Association; 2012:17-32.
49.
AikensJE.Prospective associations between emotional distress and poor outcomes in type 2 diabetes. Diabetes Care. 2012;35(12):2472-2478.
PopovMYLepikOVKozlovskiiVL, et al. Pharmacological strategies for appetite modulation in eating disorders: a narrative review. Consort Psychiatr. 2023;4(2):79-90.
52.
PetryNFosterNCengizE, et al. Substance use in adults with type 1 diabetes in the T1D Exchange. Diabetes. 2018;67(suppl 1):216.
53.
WalterKNWagnerJACengizE, et al. Substance use disorders among patients with type 2 diabetes: a dangerous but understudied combination. Curr Diab Rep. 2017;17:2. doi:10.1007/s11892-017-0832-0
54.
ModzelewskiKLRybinDVWeinbergJMAlexanianSMMcDonnellMESteenkampDW.Active cocaine use does not increase the likelihood of hyperglycemic crisis. J Clin Transl Endocrinol. 2017;9:1-7. doi:10.1016/j.jcte.2017.05.004
55.
MalinovskáJUrbanováJLustigováMKuc̆eraKBrožJ.Diabetes mellitus and illicit drugs. Vnitr Lek. 2020;66(5):52-55.
56.
GieseDKinneyGGenoC, et al. Cannabis use, diabetes self-management, and diabetic ketoacidosis (DKA) in adults with type 1 diabetes (T1D). Diabetes. 2021;70(suppl):1114-P.
57.
SullivanLETetraultJMBraithwaiteRSTurnerBJFiellinDA.A meta-analysis of the efficacy of nonphysician brief interventions for unhealthy alcohol use: implications for the patient-centered medical home. Am J Addict. 2011;20:343-356.
58.
Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff A clinical practice guideline for treating tobacco use and dependence: 2008 update. A US Public Health Service report. Am J Prev Med. 2008;35:158-176.
59.
LeungGYZhangJLinWClarkRE.Behavioral health disorders and adherence to measures of diabetes care quality. Am J Manag Care. 2011;17:144-150.
60.
BiesselsGJDearyIJRyanCM.Cognition and diabetes: a lifespan perspective. Lancet Neurol. 2008;7(2):184-190.
61.
GudalaKBansalDSchifanoFBhansaliA.Diabetes mellitus and risk of dementia: a meta-analysis of prospective observational studies. J Diabetes Investig. 2013;4:640-650.
62.
LuchsingerJATangMXSternY, et al. Diabetes mellitus and risk of Alzheimer’s disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol. 2001;154:635-641.
63.
LuchsingerJAReitzCPatelB, et al. Relation of diabetes to mild cognitive impairment. Arch Neurol. 2007;64:570-575.
64.
RyanCM.Why is cognitive dysfunction associated with the development of diabetes early in life? The diathesis hypothesis. Pediatr Diabetes. 2006;7:289-297.
65.
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med. 2007;356:1842-1852.
66.
LuchsingerJA.Diabetes, related conditions, and dementia. J Neurol Sci. 2010;299(1-2):35-38.
67.
FergusonSCBlaneAWardlawJ, et al. Influence of an early-onset age of type 1 diabetes on cerebral structure and cognitive function. Diabetes Care. 2005;28:1431-1437.
68.
DahlquistGKallenB.School performance in children with type 1 diabetes—a population-based register study. Diabetolo-gia. 2007;50:957-964.
69.
WassermanRMAndersonBJSchwartzDD.Screening of neurocognitive and executive functioning in children, adolescents, and young adults with type 1 diabetes. Diabetes Spectr. 2016;29(4):202-210.
70.
PaltaPSchneiderALBiesselsGJ, et al. Magnitude of cognitive dysfunction in adults with type 2 diabetes: a meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains. J Int Neuropsychol Soc. 2014;20(3):278-291.
71.
ChristmanALVannorsdallTDPearlsonGDHill-BriggsFSchretlenDJ.Cranial volume, mild cognitive deficits, and functional limitations associated with diabetes in a community sample. Arch Clin Neuropsychol. 2010;25(1):49-59.
72.
Institute of Medicine. Health care response to cognitive aging. In BlazerDGYaffeKLivermanCT, eds. Cognitive Aging: Progress in Understanding and Opportunities for Action. National Academies Press; 2015:209-226. Accessed March 1, 2018. https://nap.nationalacademies.org/read/21693/chapter/9#225
73.
American Diabetes Association. Older adults: standards of medical care in diabetes 2018. Diabetes Care. 2018;41(S1):S119-S125.
74.
CordellCBBorsonSBoustaniM, et al. Alzheimer;s Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting. Alzheimers Dement. 2013;9(2):141-150.
75.
Hill-BriggsFSmithAS.Evaluation of diabetes and cardiovascular disease print patient education materials for use with low-health literate populations. Diabetes Care. 2008;31(4):667-671.
76.
Hill-BriggsFLazoMRenoskyREwingC.Usability of a diabetes and cardiovascular disease education module in an African American, diabetic sample with physical, visual, and cognitive impairment. Rehab Psychol. 2008;53(1):1-8.
77.
OlfsonMGerhardTHuangC, et al. Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry. 2015:72(12):1172-1181.
78.
De HertMCorrellCUBobesJ, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011;10:52-77.
79.
MooreSShiersDDalyB, et al. Promoting physical health for people with schizophrenia by reducing disparities in medical and dental care. Acta Psychiatr Scand. 2015;132:109-121.
80.
OsbyUBrandtLCorreiaN, et al. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatr. 2001;58:844-850.
81.
CuijpersPVogelzangsNTwiskJ.Comprehensive meta-analysis of excess mortality in depression in the general com-munity versus patients with specific illnesses. Am J Psychiatry. 2014;171:453-462.
82.
WhitleyRCampbellDR.Stigma, agency and recovery amongst people with severe mental illness. Soc Sci Med. 2014;107:1-8.
83.
SiltonNRFlannellyKJMilsteinGVaalerML.Stigma in America: has anything changed? Impact of perceptions of mental illness and dangerousness on the desire for social distance: 1996 and 2006. J Nerv Ment Dis. 2011;199:361-366.
84.
KnaakSMantlerESzetoA.Mental illness-related stigma in healthcare: barriers to access and care and evidence-based solutions. Healthc Manage Forum. 2017;30(2):111-116.
85.
YanosPTRoeDMarkusKLysakerPH.Pathways between internalized stigma and outcomes related to recovery in schizophrenia spectrum disorders. Psychiatr Serv. 2008;59:1437-1442.
86.
CorriganPWMittalDReavesCM, et al. Mental health stigma and primary care decisions. Psychiatry Res. 2014;218:35-38.
87.
GoldbergRWKreyenbuhlJAMedoffDR, et al. Quality of diabetes care among adults with serious mental illness. Psychriatr Serv. 2007;58:536-543.
88.
ScottDPalatania-PhungCHappellB.Quality of care for cardiovascular disease and diabetes amongst individuals with serious mental illness and those using antipsychotic medications. J Healthc Qual. 2012;34:15-21.
89.
DixonLBKreyenbuhlJADickersonFB, et al. A comparison of type 2 diabetes outcomes among persons with and without severe mental illness. Psychiatr Serv. 2004;55:892-900.
90.
BrownCHMedoffDDickersonFB, et al. Long-term glucose control among type 2 diabetes patients with and without severe mental illness. J Nerv Ment Dis. 2011;199:899-902.
91.
HammJABuckKDGonzalvoJD.Clinical application of patient centered approach to diabetes care for people with serious mental illness. Clin Diabetes. 2017;35(5):313-320.
92.
LawrenceDKieselySPaisJ, et al. The epidemiology of excess mortality in people with mental illness. Can J Psychiatry. 2010;55(12):752-760.
93.
Antipsychotics. Lexi-drugs. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. http://online.lexi.com. Accessed August 29, 2018.
94.
RiordanHJAntoniniPMurphyMF.Atypical antipsychotics and metabolic syndrome in patients with schizophrenia: risk factors, monitoring, and healthcare implications. Am Health Drug Benefits. 2011;4(5):292-302.
95.
SattarNLeeMMYKristensenSL, et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials. Lancet Diabetes Endocrinol. 2021;9(10):653-662.
96.
GersteinHSattarN.Reduction in heart failure outcomes with SGLT2 inhibitors irrespective of glycaemic status. Lancet Diabetes Endocrinol. 2022;10(12):831-832.
97.
PalmerSCTendalBMustafaRA, et al. Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials. BMJ. 2021;372:m4573. doi:10.1136/bmj.m4573.
98.
WhartonSRaiberLSerodioKLeeJChristensenRA.Medications that cause weight gain and alternatives in Canada: a narrative review. Diabetes Metab Syndr Obes. 2018;11:427-438. doi:10.2147/dmso.s171365
99.
EbbertJOWyattKDHaysJT, et al. Varenicline for smoking cessation: efficacy, safety, and treatment recommendations. Patient Prefer Adherence. 2010;4:355-362.
100.
AnthenelliRMBenowitzNLWestR, et al. Neuropsy-chiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016;387:2507-2520.
101.
AdedinsewoDTakeNAgasthiP, et al. Prevalence and factors associated with statin use among a nationally representative sample of US adults: National Health and Nutrition Examination Survey, 2011-2012. Clin Cardiol. 2016;39(9):491-496. doi:10.1002/clc.22577
102.
TrompetSvanVlietPdeCraenAJollesJBuckleyBMurphyM.Pravastatin and cognitive function in the elderly. Results of the PROSPER study. J Neurol. 2010;257:85-90.
WagstaffLRMittonMWArvikBMDoraiswamyPM.Statin-associated memory loss: analysis of 60 case reports and review of the literature. Pharmacotherapy. 2003;23:871-880.
106.
OlmastroniEMolariGDe BeniN, et al. Statin use and risk of dementia or Alzheimer’s disease: a systematic review and meta-analysis of observational studies. Eur J Prev Cardiol. 2022;29(5):804-814.
107.
Van VlietPvan de WaterWde CraenA, et al. The influence of age on the association between cholesterol and cognitive function. Exp Gerontol. 44:112-122.
108.
MuldoonMRyanCSereikaSFloryJManuckS.Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adults. Am J Med2004;117:823-829.
109.
CramerCHaanMGaleaSLangaKKalbfleischJ.Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study. Neurology2008;71:344-350.
110.
ParkerBAPolkDMRabdiyaV, et al. Changes in memory function and neuronal activation associated with atorvastatin therapy. Pharmacotherapy. 2010;30:236e-240e.
111.
ZamriniEMcGwinGRosemanJM.Association between statin use and Alzheimer’s disease. Neuroepidemiology. 2004;23:94-98.
112.
MuldoonMBargerSRyanC, et al. Effects of lovastatin on cognitive function and psychological well-being. Am J Med. 2000;108:538-547.
113.
ZandiPPSparksDLKhachaturianAS, et al. Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study. Arch Gen Psychiatry. 2005;62:217-224.
114.
SamarasKMakkarSCrawfordJ, et al. Effects of statins on memory, cognition and brain volume in elderly. J Am Coll Cardiol. 2019;74(21):2554-2568.
115.
ZhouBTeramukaiSFukushimaM.Prevention and treatment of dementia or Alzheimer’s disease by statins: a meta-analysis. Dement Geriatr Cogn Disord. 2007;23:194-201.
116.
BeydounMABeason-HeldLLKitner-TrioloMH, et al. Statins and serum cholesterol’s associations with incident dementia and mild cognitive impairment. J Epidemiol Community Health. 2011;65:949-957.
117.
MansiIFreiCRPughMMortensenEM.Psychological disorders and statin use: a propensity scorematched analysis. Pharmacotherapy. 2013;33(6):615-626.
118.
WangBAnXShiX, et al. Management of endocrine disease: suicide risk in patients with diabetes: a systematic review and meta-analysis. Eur J Endocrinol. 2017;177(4):R169-R181.
119.
LutzJMortonKTurianoNA, et al. Health conditions and passive suicidal ideation in the survey of health, ageing, and retirement in Europe. J Gerontol B Psychol Sci Soc Sci. 2016;71(5):936-946.
120.
WangYTangSXuS, et al. Association between diabetes and risk of suicide death: a meta-analysis of 3 million participants. Compr Psychiatry. 2016;71:11-16.
121.
SarkarSBalharaYP.Diabetes mellitus and suicide. Indian J Endocrinol Metab. 2014:18(4):468-474.
122.
ClementSSchaumanOGrahamT, et al. What is the impact of metal health-related stigma on help-seeking?: A systematic review of quantitative and qualitative studies. Psychol Med. 2015;45(1):11-27.
123.
CorriganP.How stigma interferes with mental health care. Am Psychol. 2004;59(7):614-625.
124.
MajidiShidehO’DonnellHKStanekKYoungkinEGomerTDriscollKA. Suicide risk assessment in youth and young adults with type 1 diabetes. Diabetes Care. 2020;43(2):343-348. doi:10.2337/dc19-0831
CerettaLBReusGZAbelairaHM, et al. Increased prevalence of mood disorders and suicidal ideation in type 2 diabetic patients. Acta Diabetol. 2012;49(1)227-234. doi:10.1007/s00592-012-0435-9
127.
HuangCJHuangYTLinPCHsiehHMYangYH.Morality and suicide related to major depressive disorders before and after type 2 diabetes mellitus. J Clin Psychiatry. 2022:83(1):20m13692. doi:10.4088/JCP.20m13692
HillJNielsenMFoxMH.Understanding the social factors that contribute to diabetes: informing health care and social policies for the chronically ill. Perm J. 2013;17(2)67. doi:10.7812/TPP/12-099
134.
Hill-BriggsFAdlerNBerkowitzS, et al. Social determinants of health and diabetes: a scientific review. Diabetes Care. 2021;44(1):258-279. doi:10.2337/dci20-0053
135.
AdlerNENewmanK.Socioeconomic disparities in health: pathways and policies. Health Aff (Millwood). 2022;21:60-76.
136.
ElSayedNAleppoGArodaV, et al. Standards of care in diabetes - 2023. Diabetes Care. 2023;46(1):S1-S4.
137.
LuceneteGSoninoNFavaG.Allostatic load and its impact on health: a systematic review. Psychother Psychosom. 2021;90(11):11-27. doi:10.1159/000510696
138.
Bijlsma-RutteARuttersFEldersPJM, et al. Socio-economic status and HbA1c in type 2 diabetes: a systematic review and meta-analysis. Diabetes Metab Res Rev. 2018;34:3008. doi:10.1002/dmrr.3008
139.
Hills-BriggsFLazoMPeyrotM, et al. Effect of problem-solving based diabetes self-management training on diabetes control in low-income patient sample. J Gen Intern Med. 2011;26:972-978.
140.
CavanaughKWallstonKAGebtretsadikT, et al. Addressing literacy and numeracy to improve diabetes care: two-randomized controlled trials. Diabetes Care. 2009;32;2149-2155.
141.
KazemianPSheblFMMcCannN, et al. Evaluation of the cascade of diabetes care in the United States, 2005-2016. JAMA Intern Med. 2019;179:1376-1385.
142.
LieseADMaXReifL, et al. Health care access and glycemic control in youth and young adults in type 1 and type 2 diabetes in South Carolina. Pediatr Diabetes. 2019;20:321-329.
143.
Ngo-MetzgerQSorkinDHBillimekJ, et al. The effects of financial pressures on adherence and glucose control among racial/ethnically diverse patients with diabetes. J Gen Intern Med. 2012;27:432-437.
144.
KushelMBGuptaRGeeL, et al. Housing instability and food insecurity as barriers to health care among low-income Americans. J Gen Intern Med. 2006;21:71-77.
145.
AhernMBrownCDukasS.A national study of the association between food environments and county-level health outcomes. J Rural Health. 2011;27:367-379.
146.
SeligmanHKSmithMRosenmossS, et al. Comprehensive diabetes self-management support from food banks: a randomized controlled trial. Am J Public Health. 2018;108:1227-1234.
147.
RivichJKosirogERBillupsSJ, et al. Social and psychosocial determinants of health associated with uncontrolled diabetes in a federally qualified health center population. Diabetes Spectr. 2019;32(2):145-151. doi:10.2337/ds18-0064
148.
StromJLEgedeLE.The impact of social support on outcomes in adult patients with type 2 diabetes: a systematic review. Curr Diab Rep. 2012;12:769-681.
149.
988 Suicide and Crisis Lifeline. [Home page]. Accessed September 3, 2024. 988liifeline.org
150.
Indian Health Service Division of Diabetes Treatment and Prevention in collaboration with Indian Health Service Tribal Leaders Diabetes Committee and Tribal Community Members. A River Runs Through Us: Inspirations of Wellness. US Government Printing Office;2009.
151.
CaballeroAE.Diabetes in the Hispanic or Latino population: genes, environment, culture and more. Curr Diab Rep. 2005;5(3):217-225. doi:10.1006/s11892-005-0012-5
152.
PetersonCMDavisB.Lifestyle intervention to treat diabetes in the Marshall Islands. The Martial Islands Diabetes Intervention Project. Updated May16, 2023. Accessed 2016. Accessed March 5, 2019. https://www.clinicaltrials.gov/ct2/show/NCT03862963
SchmittAReimerAHarmannsN, et al. Depression is linked to hyperglycaemia via suboptimal diabetes self-management: a cross-sectional mediation analysis. J Psychosom Res. 2017;94:17-23.
158.
PowersMABardsleyJCypressM, et al. Diabetes self-management education and support in type 2 diabetes: a joint position statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics. Diabetes Educ. 2015;41(4):417-430.